Whittier Trust’s Agios Pharmaceuticals AGIO Stock Holding History

Whittier Trust’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-79	Closed	-$3K	–	1513
2019 Q3	$3K	Buy	+79	New	+$3.27K	﹤0.01%	1313

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Whittier Trust's AGIO Position: Q4 2019 in Review

Whittier Trust sold out of Agios Pharmaceuticals (AGIO) in Q4 2019, closing a stake of 79 shares — an estimated $3K sold.

Whittier Trust first reported a position in AGIO in Q3 2019 and held it in 1 quarter. The position peaked at $3K in Q3 2019. 198 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

Whittier Trust reported no remaining Agios Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Whittier Trust sold 79 Agios Pharmaceuticals shares in Q4 2019, an estimated $3K.
Whittier Trust first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 1 quarter.
Whittier Trust's Agios Pharmaceuticals position peaked at $3K in Q3 2019.
198 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Whittier Trust's 13F filing for Q4 2019, filed 31 Jan 2020.